Transcription:
Advances in Breast Cancer Care
Melanie Cole, MS (Host): Welcome to Bryan Health Podcast. I'm Melanie Cole. And today, we are highlighting breast cancer treatments. Joining me is Dr. Rachel Jendro. She's a breast surgical oncologist with Bryan Health.
Dr. Jendro, thank you so much for joining us today. So as we begin, I'd like you to tell us a little bit about breast cancer. What are you seeing as far as incidence and awareness? Are more women getting screened? What are you seeing in the trends?
Dr. Rachel Jendro: Well, Melanie, thank you so much for having me on. This is such an important topic and great to talk about we know that one in eight women will develop breast cancer. So, it is not uncommon. And just to be aware of your own body and be aware of those screening recommendations, that's the most important thing, to catch that breast cancer early.
Melanie Cole, MS: Well, tell us about the different types of breast cancer, and I know some of it you don't even find out until maybe you've had a biopsy or such, but there are different types. And how are the hormone receptors and proteins that promote the growth of those cancer cells used to identify those treatments? Tell us about the different types.
Dr. Rachel Jendro: So, you have a few different types. The most common type is invasive ductal carcinoma, and that represents about 70% to 80% of all breast cancer. Next would be invasive lobular carcinoma. That's around 15-ish percent. And then, you have a few more uncommon types. There's inflammatory breast cancer, Paget's disease, metaplastic. Those are less common. So, that most common one is the invasive ductal carcinoma.
We also see ductal carcinoma in situ, which is a stage 0 cancer cells inside the milk duct, and that can sometimes progress to that invasive ductal carcinoma. And like you said, we do check receptors on all breast cancers, and what that's meaning is, is there an estrogen receptor and a protein receptor on the actual cancer cell that can feed from those hormones that can make that cancer grow?
And all cancers are different. You know, everyone is so different with what their type and receptors are. We also check that HER2 receptor, which is that protein receptor. And this is not like protein that you eat. This is our bodies can make proteins that will attach to that receptor and can make that breast cancer grow. So, everyone is very unique in their type and their receptor status.
Melanie Cole, MS: That was a great explanation. Thank you. So, tell us a little bit about risk and genetic predisposition. I know that we've heard a lot about the BRCA gene mutation. Tell us about risk factors and that mutation.
Dr. Rachel Jendro: Risk factors for breast cancer include—we know that tobacco increases your risk. We know that alcohol increases the risk. Being overweight can increase that risk. The deal there is our body is lined with fat cells. We all have fat cells, and those fat cells make estrogen and they make hormones. So, the more overweight we are, the more hormones we're pumping into the system, which can increase that risk for breast cancer.
We know that family history can increase our risk, and those folks with that family history should get tested for genetics, but, you know, anyone can get genetic testing. And there are, I don't know, several, several breast cancer genes that we know about now. That first one that was ever discovered was the BRCA 1 and 2. The BRCA 1 folks have up to an 80% chance of developing breast cancer, so it's very high risk. And a lot of those folks will choose to have preventative surgery to decrease that risk. But, you know, only 10% of all breast cancer is caused by a gene.
Melanie Cole, MS: Well, that's really interesting to know. That is such great information for women that are really curious. Now, let's talk about imaging, screening, and signs. First of all, we're doing our self-checks. So, can you tell us a little bit about that and what we might feel? Because, you know, our breasts are lumpy and things move around and change, and how are we supposed to know what we're feeling?
Dr. Rachel Jendro: You're so right. It can be very intimidating to do your own breast exam. And a lot of my patients will tell me, "I just don't do them because everything feels lumpy and it's just scary." So, the general recommendation is for folks to start in their 20s doing their own self-breast exams to really get used to what your tissue feels like. So, try to do this once a month. In the shower is a little easier, because you can just feel things better when you're soapy. But breast tissue is lumpy, and the deal is get used to what's normal for you, so then you know if something is new, it wasn't there last time you checked, then that's something to get checked out. Normal tissue will move fairly easy. But if there's a hard, stuck-feeling mass that's new, that can be concerning.
Other things to look for include rashes in the breast that don't go away any nipple changes such as the nipple getting hard, red, inverted, new nipple discharge. These are all things that definitely need to get checked out.
Melanie Cole, MS: Now, tell us about screening. What is the screening recommendations as of now? Because they also can be a little bit confusing. Tell us about 3D mammograms and any other options that are out there.
Dr. Rachel Jendro: Mammogram is still recommended that we get that at age 40, and you're totally right. You hear some different guidelines from some different societies, but we still look at the American Cancer Society, the American Society of Breast Surgeons' recommendations are to start your mammograms at age 40 and to have them every year.
The 3D mammograms are very standard now. You know, those came along several years ago, and it took a while for insurance to start paying for those. But now, it is standard across the board. It should always be a 3D mammogram. Some patients will be recommended to start those mammograms earlier, depending on family history. So, we typically say to start 10 years younger than the family member who was diagnosed. So, it's really tailoring that specific to the patient as well.
Ultrasounds are also an option for imaging. This can help when patients have very dense breast tissue. You know, you'll get this report on your mammogram saying that you have dense breast tissue, and we may not be able to see that well through the tissue, which can be very concerning for a patient to see that on their report. So, ultrasounds can be used in addition to those mammograms to just really make sure they're getting a good picture.
Now, a breast MRI also is an option, and especially for our high-risk patients and with dense breast tissue, that just adds another layer of really visualizing the breast tissue.
Melanie Cole, MS: That was an excellent explanation of the different options that are out there for screening. Now, if we, get diagnosed, they see something, then there are a few steps that go into finding out if it is truly cancerous. Tell us about that process. What does a woman do when she gets that notification? To whom does she turn, and what are the next steps?
Dr. Rachel Jendro: Typically, how it goes is the patient will get her just routine screening mammogram, and then this will tell them if there are any abnormalities or any concerns. If there is a concerning area, that next step will be to get a diagnostic mammogram and an ultrasound and potentially that MRI. And if there's still concerns, that would then lead to a biopsy of the concerning area for a diagnosis.
So, the biopsy will tell us if it's breast cancer or not, and if it is, what type it is, what our receptors are, how do we need to proceed with our next steps. And then, we get into discussing surgical options if chemotherapy is needed, and how radiation can play into that as well.
Melanie Cole, MS: Well then, tell us about those, Dr. Jendro. What are the surgical options? And then, speak a little bit about whether someone needs chemo or radiation.
Dr. Rachel Jendro: From the surgical side of things, we in general have three different options for treating breast cancer. This would include a lumpectomy, which is removing the cancer but not the whole breast. You can have a mastectomy without reconstruction or a mastectomy with reconstruction.
Now, there's also the option of an oncoplastic reduction. This is where the plastic surgeon and myself work together. And I would remove the breast cancer with a lumpectomy, and then the plastic surgeon does a breast lift and reduction at the same time on both sides. So, that's also another way of going about this. With a lumpectomy, we typically do radiation therapy to the breast after surgery. The point of that is to decrease the risk of the cancer coming back. So in general, if you do a lumpectomy, the risk of that cancer coming back, depending on the receptors and the grade, can be maybe 10% to 20% percent. And then, if you add the radiation, then that cuts that risk in half. So, you go down to at least 5% to 7% percent. So, it's a big drop in risk.
And radiation can sound very scary to some people, but the main side effects are really skin changes. You don't lose your hair, you don't get sick, you don't feel the radiation treatment. You get some skin changes, and then that fades away over time. So, very well-tolerated and really decreases the risk.
Typically, with a mastectomy, radiation is not recommended. That recommendation would come in if the cancer was over five centimeters or if we had lymph nodes involved with cancer. Then, that may bring radiation in with a mastectomy. If a patient's interested in reconstruction, then I would refer them to one of the plastic surgeons, and they discuss options for reconstruction. And then, I work together with that plastic surgeon, and we do the surgery together.
Melanie Cole, MS: Now, tell us about chemotherapy and when we've had the surgery to remove the cancer, do you then find out the path forward as to whether the woman is going to need some type of systemic therapy like that? And tell us what she can expect if that is the case.
Dr. Rachel Jendro: So, chemotherapy, you know, is recommended by the medical oncologist,
So if someone is triple negative, so we have our estrogen, progesterone, and that HER2 receptor are negative, those folks in general will require chemotherapy because that's a little more aggressive type, and they will have a better outcome, a better long-term prognosis with chemotherapy.
Now, depending on the size of the cancer, we can do it before surgery, and sometimes we do it after. And that's where we work in conjunction in our multidisciplinary team to discuss the patients and really go over the plan from all aspects on how to move forward with that treatment. There is a test called an Oncotype test, and this can be sent off on certain cancers, and it's just goes to a lab, and they process that tumor, and the score comes back as a number on a scale. And a low number on that scale says you don't need chemotherapy. A higher number says you would benefit from chemotherapy.
So in an estrogen-progesterone positive patients, that often is sent, and that helps the medical oncologist decide if chemo is needed or not. You can also use different pills. So, there are hormone blocker pills that people can take. This is when we're estrogen and progesterone positive, meaning that cancer feeds from our hormones. There are four or five different ones of those medications. That includes tamoxifen, Arimidex, Femara, Aromasin. There's a variety of those medications. And that, again, is recommended by medical oncology and typically our patients who are estrogen, progesterone positive. That decreases recurrence risk and protects them from breast cancer in the future.
Melanie Cole, MS: Dr. Jendro, how is a woman's self-esteem, peace of mind taken into account when deciding on these types of treatments? Because I know it's very individual, and as you've said, the type of tumor is really unique to each woman. So, how do you work with women? You mentioned the multidisciplinary approach and your medical oncologist. So, there's a lot of people involved. Tell us how you work with women so that they feel validated and heard.
Dr. Rachel Jendro: This is such a scary time. No one wants to hear you have breast cancer. So, I'm very aware of it is a huge uplift and change in their life and their family's lives. It's not just that patient, but their families feel out of control and that they can't fix it, and it's very scary for the patient and the family. So, we spend a lot of time at that first visit just reviewing, you know, what this is, what our options are, and I definitely have the patient give their input on what their preference is for surgery. We go over their options, their recurrence risk.
Typically, your prognosis is based on stage, not on the type of surgery you have. You know, a lot of folks will come in thinking, "I just need to have bilateral mastectomies. That's got to be better." But it doesn't make you 0% for a recurrence. So, it's really just going over the true numbers of what your options are. The recurrence risk is basically the same, and the prognosis is no different. So, they don't have to have a mastectomy if they don't want to. So, we really go over what their desire is, what is best for them. As long as we can have a great cancer treatment and therapy, I want them to feel in control of what we're doing. And if they want to discuss a mastectomy, we can also discuss if they're a nipple-sparing mastectomy candidate or not. That's where we save the nipple. So, when patients look at themselves, it still looks like them, so they still feel like themselves and feel whole. So, there are a lot of ways of going about making sure they feel okay, making sure it's the right procedure for them. We also have great mental health therapists at the cancer center that we use quite a bit as well.
Melanie Cole, MS: This has been great advice, Dr. Jendro. You are an excellent educator. Give us your final thoughts on what you want women to know about the importance of being our own best health advocate and getting our screenings, and if we have any questions to talk with our physicians.
Dr. Rachel Jendro: The most important thing is to catch breast cancer early. The earlier the stage, the better the outcome. So if you can get that mammogram every year and really know your body and catch things early, people do so much better. Our stage I breast cancer folks have a 99% prognosis. So, it's excellent, excellent prognosis with early stage. So, that's the most important thing, is taking care of yourself. You know, women put everybody else in front of them, their kids, their family, their spouse, their job. So, you need to take care of yourself and make yourself the priority and take care of getting that mammogram every year.
Melanie Cole, MS: Thank you so much, Dr. Jendro, for joining us today and really sharing your incredible expertise. And I'd also like to thank our Bryan Foundation partner, Fiducient Advisors. To listen to more podcasts from our experts, please visit bryanhealth.org/podcasts. That concludes this episode of Bryan Health Podcast. Please remember to subscribe, rate, and review Bryan Health Podcast on Apple Podcasts, Spotify, iHeart, and Pandora. Until next time, I'm Melanie Cole.